Categories: USA

POTUS promotes hydroxychloroquine as coronavirus treatment once again

The efficacy of the hydroxychloroquine has been disputed by several trials so far. However, President Donald Trump once again promoted it as a treatment for the coronavirus infection. With this promotion, Trump went against the recommendations of the Food and Drug Administration (FDA). He retweeted a video on Twitter which called hydroxychloroquine a “cure” for COVID-19.

The video has been pulled by Facebook, Twitter, and YouTube since then. Twitter also took a step against the son of Trump, Donald Trump Jr., due to this video. The account of Trump’s son has been suspended by the Twitter administration. The FDA said that the peer-reviewed trials of the drug did not produce promising results. The Administration banned the usage of this drug as a COVID-19 cure outside of the hospital.

Trump said that he had believed in hydroxychloroquine. “As you know, I took it for a 14-day period, and I’m here,” he said on Tuesday. The Henry Ford Health System conducted a study that indicated the positive results of the drug. The White House promoted started promoting that study. However, a study released by the New England Journal of Medicine revealed that the drug did not improve coronavirus outcomes.

According to the FDA, the use of hydroxychloroquine has dangerous side effects. The use of this drug is only allowed on an experimental base. The FDA said in April, “The hydroxychloroquine or chloroquine has not been shown to be safe or effective for treating or preventing COVID-19.” One of the main side effects of this drug is abnormal heart rhythms.

The patients already having health issues can suffer from further complexities due to the use of this drug, according to the FDA. The hydroxychloroquine or chloroquine is used for the treatment of malaria and lupus. However, Trump has promoted this drug as a cure for COVID-19 several times in the past as well. He said, “I happen to believe in it. I would take it.”

Shawn Genzone

Senior writer at the Chicago Morning Star

Recent Posts

DeRozan, Kings Top Knicks as Bulls Win Thriller

DeMar DeRozan scored 27 points, and Zach LaVine added 25 as the Sacramento Kings earned their third straight win, defeating…

2 days ago

Chicago Employment Index Falls to Lowest Level Since 2009

Chicago businesses recorded their weakest employment reading in more than a decade, according to new data released by the Illinois…

2 days ago

Chicago Small Businesses Enter 2026 With Cautious Outlook

As 2026 begins, small businesses across Chicagoland are adjusting expectations after a year defined by economic uncertainty, according to new…

3 days ago

Illinois Approves New Regional Transit Authority Overhaul

Illinois lawmakers have approved a major overhaul of public transportation governance in the Chicago region, creating a new regional oversight…

5 days ago

Mammoth Seek Wild-Card Push vs. Blues in Salt Lake

The Utah Mammoth will try to move back into playoff position Friday night when they host the St. Louis Blues…

1 week ago

Phillies to Meet With Free Agent Shortstop Bo Bichette

The Philadelphia Phillies have scheduled a meeting with free agent shortstop Bo Bichette, according to a report by The Athletic.…

1 week ago

This website uses cookies.